Cargando…

NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic

The severity of the coronavirus disease in 2019 (COVID-19) is strongly linked to a dysregulated immune response. This fuels the fear of severe disease in patients with autoimmune disorders continuously using immunosuppressive/immunomodulating medications. One complication of COVID-19 is thromboembol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knopf, Jasmin, Sjöwall, Johanna, Frodlund, Martina, Hinkula, Jorma, Herrmann, Martin, Sjöwall, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455008/ https://www.ncbi.nlm.nih.gov/pubmed/36078028 http://dx.doi.org/10.3390/cells11172619

Ejemplares similares

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic
por: Sjöwall, Johanna, et al.
Publicado: (2021)

Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients
por: Frodlund, Martina, et al.
Publicado: (2021)

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register
por: Frodlund, Martina, et al.
Publicado: (2013)

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus
por: Heijke, Rebecca, et al.
Publicado: (2020)

Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study
por: Heijke, Rebecca, et al.
Publicado: (2021)

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
por: Frodlund, M, et al.
Publicado: (2019)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2020)

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2022)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
por: Parodis, Ioannis, et al.
Publicado: (2020)

B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools
por: Parodis, Ioannis, et al.
Publicado: (2022)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
por: Sohrabian, Azita, et al.
Publicado: (2019)

Neutrophil Extracellular Traps (NETs) in the Cerebrospinal Fluid Samples from Children and Adults with Central Nervous System Infections
por: Appelgren, Daniel, et al.
Publicado: (2019)

Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register
por: Ighe, Anna, et al.
Publicado: (2015)

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
por: Hedenstedt, Anna, et al.
Publicado: (2023)

The diagnostic accuracies of the 2012 SLICC criteria and the proposed EULAR/ACR criteria for systemic lupus erythematosus classification are comparable
por: Dahlström, Ö, et al.
Publicado: (2019)

Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus
por: Björk, Mathilda, et al.
Publicado: (2015)

The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes
por: Skoglund, Oliver, et al.
Publicado: (2022)

Case definitions in Swedish register data to identify systemic lupus erythematosus
por: Arkema, Elizabeth V, et al.
Publicado: (2016)

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2004)

Impaired Microcirculation and Vascular Hemodynamics in Relation to Macrocirculation in Patients With Systemic Lupus Erythematosus
por: Svensson, Christina, et al.
Publicado: (2021)

Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity
por: Karlsson, Jesper, et al.
Publicado: (2022)

Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2019)

High-Frequency Ultrasound of Multiple Arterial Areas Reveals Increased Intima Media Thickness, Vessel Wall Appearance, and Atherosclerotic Plaques in Systemic Lupus Erythematosus
por: Svensson, Christina, et al.
Publicado: (2020)

Formation and Clearance of NETs in Health and Disease
por: Knopf, Jasmin, et al.
Publicado: (2022)

Contributions of de novo variants to systemic lupus erythematosus
por: Almlöf, Jonas Carlsson, et al.
Publicado: (2020)

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
por: Reid, Sarah, et al.
Publicado: (2020)

Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE
por: Wirestam, Lina, et al.
Publicado: (2017)

Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus
por: Wirestam, Lina, et al.
Publicado: (2021)

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study
por: Walhelm, Tomas, et al.
Publicado: (2021)

Epidemiology and Damage Accrual of Systemic Lupus Erythematosus in Central Sweden: A Single‐Center Population‐Based Cohort Study Over 14 Years From Östergötland County
por: Arkema, Elizabeth V., et al.
Publicado: (2023)

Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis
por: Heijke, Rebecca, et al.
Publicado: (2021)

Sex differences in clinical presentation of systemic lupus erythematosus
por: Ramírez Sepúlveda, Jorge I., et al.
Publicado: (2019)

Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus: An Observational Study from a Single Centre in Sweden
por: Saleh, Muna, et al.
Publicado: (2020)

Autoantibodies associated with primary biliary cholangitis are common among patients with systemic lupus erythematosus even in the absence of elevated liver enzymes
por: Ahmad, A., et al.
Publicado: (2020)

Limited Association between Antibodies to Oxidized Low-Density Lipoprotein and Vascular Affection in Patients with Established Systemic Lupus Erythematosus
por: Wirestam, Lina, et al.
Publicado: (2023)

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE
por: Arkema, Elizabeth V., et al.
Publicado: (2016)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6hifs48c73ite8vo6ee95mq4is